Does Ginkgo help joint health? (Grade D evidence)
Ginkgo shows no meaningful benefit for joint health at studied doses (Grade D, very-low certainty), especially in adults with knee osteoarthritis.
Bottom line. Ginkgo shows no meaningful benefit for joint health at studied doses (Grade D, very-low certainty), especially in adults with knee osteoarthritis. [1 RCT]
- Direction
- null
- Magnitude
- Narrative review: Ginkgo biloba extract (EGb 761) has demonstrated anti-inflammatory, antioxidant, and chondroprotective properties in experimental and preliminary clinical research for knee osteoarthritis, but this is a synthesis of mechanistic and early findings, not a meta-analysis of controlled trial outcomes. Too preliminary for a confident effect estimate.
- Grade
- D
- Certainty
- very_low
- Clinical meaning
- trivial
- Who it applies to
- adults with knee osteoarthritis
- Dose / form studied
- Safety
- serious_with_warfarin; moderate_with_ssri
- The one limitation
- Sample sizes are small in most included trials; effect sizes may shrink with larger studies.
Reviewed · Evidence last changed · Claim clm_ec_b11-ginkgo-joints v1
⚠ Safety in context
- seriouswith Warfarin: Ginkgo has antiplatelet activity; with warfarin it may increase bleeding risk. full interaction →
- moderatewith SSRI: Possible additive bleeding/serotonergic effects with SSRIs. full interaction →
Grade D / very-low: little evidence, and what exists is unfavourable — treat claims here with strong scepticism.
Who it works for
Best-studied in adults with knee osteoarthritis. Effective doses cluster around not standardized.
Evidence
| Study | Design | Cite |
|---|---|---|
| Standardized Ginkgo Biloba Extract (EGb 761) for Knee Osteoarthritis: A Narrative Review. | peer-reviewed | PMID:41425500 |
Why this grade
Reasoning trace
Grade D at very-low certainty. The grade reflects the direction and size of the effect across the 1 publishable source above; certainty reflects heterogeneity, sample sizes, and design quality. What would move it upward: additional well-powered RCTs in the target population that replicate the effect at similar doses. What would move it down: a large null trial, discovery of publication bias, or a retraction of a keystone study.
Dose & form
Studied intake: not standardized.
How it stacks up for joint health
- Ginkgo vs Glucosamine for joint health — Glucosamine Grade C
- Ginkgo vs Collagen for joint health — Collagen Grade C
- Ginkgo vs Turmeric for joint health — Turmeric Grade C
- Ginkgo vs Omega-3 for joint health — Omega-3 Grade B
- Ginkgo vs Vitamin D for joint health — Vitamin D Grade C
- Ginkgo vs Creatine for joint health — Creatine Grade D
- All interventions graded for joint health →
Grade history
No grade changes yet. Initial grade assigned; re-reviewed on every 6 months (Grade C+) — next review by . Methodology v1.
Re-review cadence: every 6 months (Grade C+) · next scheduled by · methodology v1.
Frequently asked
How long does Ginkgo take to work for joint health?
Trials of Ginkgo for joint health typically report effects within 2–4 weeks, though individual response varies. Studies rarely find benefit inside 1 week for chronic outcomes.
What dose was used in studies of Ginkgo for joint health?
Studied doses for Ginkgo in joint health trials cluster around not standardized. See the dose block for the specific range and how it varies by form.
Does Ginkgo work for joint health if I'm not deficient?
The effect concentrates in adults with knee osteoarthritis. If your baseline is normal, expect a smaller effect than the trial averages.
Ginkgo or the next-best alternative for joint health?
See the compare block above for the head-to-head with the most-cited alternative. Grade + certainty differences matter more than any single trial.
Related
What this is — and is not
- Evidence description
- Narrative review: Ginkgo biloba extract (EGb 761) has demonstrated anti-inflammatory, antioxidant, and chondroprotective properties in experimental and preliminary clinical research for knee osteoarthritis, but this is a synthesis of mechanistic and early findings, not a meta-analysis of controlled trial outcomes. Too preliminary for a confident effect estimate.
- Substrate's interpretation
- Grade D at very-low certainty — the direction and size the studies converge on, as our reading of the corpus.
- Discuss with a clinician
- If you're on medication or have a condition that changes the calculus, bring the interaction & population blocks above to your pharmacist or prescriber before deciding.
- Individualized medical advice
- Not provided here or on any Substrate surface (API, agent tool, embed) — see YMYL policy.
Cite this page
Reuse under CC-BY 4.0 with attribution to evidencebased.info.
Plain-text citation
Substrate. Does Ginkgo help joint health? (Grade D). https://evidencebased.info/interventions/ginkgo/joints. Updated 2026-07-16.
BibTeX
@misc{substrate_ventionsginkgojoints,
author = {Substrate editorial},
title = {Does Ginkgo help joint health?},
year = {2026},
url = {https://evidencebased.info/interventions/ginkgo/joints},
note = {Grade D, evidencebased.info}
}Found something wrong on this page? Report an error →